                         SEQUENCE LISTING

<110>  University of Helsinki
 
<120>  Viral Vector

<130>  4647P/GB

<150>  GB1907413.7
<151>  2019-05-24

<160>  28    

<170>  PatentIn version 3.5

<210>  1
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  tetanus toxin

<400>  1

Gln Tyr Ile Lys Ala Asn Ser Lys Phe Ile Gly Ile Thr Glu Leu 
1               5                   10                  15  


<210>  2
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  pertussis

<400>  2

Ala Arg Tyr Val Ser Gln Gln Thr Arg Ala Asn Pro Asn Pro Tyr 
1               5                   10                  15  


<210>  3
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  polio mahoney

<400>  3

Ile Gln Ser Lys Arg Phe Ala Pro Leu Tyr Ala Val Glu Ala Lys 
1               5                   10                  15  


<210>  4
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Diptheria

<400>  4

Ser Pro Val Tyr Val Gly Asn Gly Val His Ala Asn Leu His Val 
1               5                   10                  15  


<210>  5
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Diptheria

<400>  5

Pro Val Phe Ala Gly Ala Asn Tyr Ala Ala Trp Ala Val Asn Val Ala 
1               5                   10                  15      


Gln Val Ile 
            


<210>  6
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Pertussis

<400>  6

Ala Arg Tyr Val Ser Gln Gln Thr Arg Ala Asn Pro Asn Pro Tyr 
1               5                   10                  15  


<210>  7
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Polio Mahoney

<400>  7

Ile Gln Ser Lys Arg Phe Ala Pro Leu Tyr Ala Val Glu Ala Lys 
1               5                   10                  15  


<210>  8
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Diptheria

<400>  8

Ser Pro Val Tyr Val Gly Asn Gly Val His Ala Asn Leu His Val 
1               5                   10                  15  


<210>  9
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  gp100 antigen

<400>  9

Lys Val Pro Arg Asn Gln Asp Trp Leu 
1               5                   


<210>  10
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  NY-ESO-1 antigen

<400>  10

Ser Leu Leu Met Trp Ile Thr Gln Cys 
1               5                   


<210>  11
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  NY-ESO-1 antigen

<400>  11

Arg Gly Pro Glu Ser Arg Leu Leu Glu Phe Tyr Leu Ala Met Pro Phe 
1               5                   10                  15      


Ala Thr Pro Met 
            20  


<210>  12
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  NY-ESO-1 antigen

<400>  12

Tyr Leu Ala Met Pro Phe Ala Thr Pro Met Glu Ala Glu Leu Ala Arg 
1               5                   10                  15      


Arg Ser Leu Ala 
            20  


<210>  13
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  NY-ESO-1 Antigen

<400>  13

Arg Gly Pro Glu Ser Arg Leu Leu Glu Phe Tyr Leu Ala Met Pro Phe 
1               5                   10                  15      


Ala Thr Pro Met Glu Ala Glu Leu Ala Arg Arg Ser Leu Ala 
            20                  25                  30  


<210>  14
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  NY-ESO-1 Antigen

<400>  14

Pro Gly Val Leu Leu Lys Glu Phe Thr Val Ser Gly Asn Ile Leu Thr 
1               5                   10                  15      


Ile Arg Leu Thr Ala Ala Asp His Arg 
            20                  25  


<210>  15
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  NY-ESO-1 Antigen

<400>  15

Tyr Leu Ala Met Pro Phe Ala Thr Pro Met Glu Ala Glu Leu Ala Arg 
1               5                   10                  15      


Arg Ser Leu Ala 
            20  


<210>  16
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  NY-ESO-1 Antigen

<400>  16

Tyr Leu Ala Met Pro Phe Ala Thr Pro Met Glu Ala Glu Leu Ala Arg 
1               5                   10                  15      


Arg Ser Leu Ala Glu Glu 
            20          


<210>  17
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A3 antigen

<400>  17

Val Phe Gly Ile Glu Leu Met Glu Val Asp Pro Ile Gly His Leu Tyr 
1               5                   10                  15      


Ile Phe Ala Thr 
            20  


<210>  18
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAGE-A3 antigen

<400>  18

Val Phe Gly Ile Glu Leu Met Glu Val Asp Pro Ile Gly His Leu Tyr 
1               5                   10                  15      


Ile Phe Ala Thr 
            20  


<210>  19
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  poly lysine gp100 antigen position 25-35

<400>  19

Lys Lys Lys Lys Lys Lys Lys Val Pro Arg Asn Gln Asp Trp Leu 
1               5                   10                  15  


<210>  20
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  poly lysine NY-ESO-1 antigeb position 157-165

<400>  20

Lys Lys Lys Lys Lys Lys Ser Leu Leu Met Trp Ile Thr Gln Cys 
1               5                   10                  15  


<210>  21
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  poly lysine NY-ESO-1 antigen position 81-100

<400>  21

Lys Lys Lys Lys Lys Lys Arg Gly Pro Glu Ser Arg Leu Leu Glu Phe 
1               5                   10                  15      


Tyr Leu Ala Met Pro Phe Ala Thr Pro Met 
            20                  25      


<210>  22
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  poly lysine NY-ESO-1 antigen position 91-110

<400>  22

Lys Lys Lys Lys Lys Lys Tyr Leu Ala Met Pro Phe Ala Thr Pro Met 
1               5                   10                  15      


Glu Ala Glu Leu Ala Arg Arg Ser Leu Ala 
            20                  25      


<210>  23
<211>  36
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  poly lysine NY-ESO-1 antigen position 81-110

<400>  23

Lys Lys Lys Lys Lys Lys Arg Gly Pro Glu Ser Arg Leu Leu Glu Phe 
1               5                   10                  15      


Tyr Leu Ala Met Pro Phe Ala Thr Pro Met Glu Ala Glu Leu Ala Arg 
            20                  25                  30          


Arg Ser Leu Ala 
        35      


<210>  24
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  poly lysine NY-ESO-1 antigen position 119-143

<400>  24

Lys Lys Lys Lys Lys Lys Pro Gly Val Leu Leu Lys Glu Phe Thr Val 
1               5                   10                  15      


Ser Gly Asn Ile Leu Thr Ile Arg Leu Thr Ala Ala Asp His Arg 
            20                  25                  30      


<210>  25
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  poly lysine NY-ESO-1 antigen position 91-110

<400>  25

Lys Lys Lys Lys Lys Lys Lys Lys Lys Tyr Leu Ala Met Pro Phe Ala 
1               5                   10                  15      


Thr Pro Met Glu Ala Glu Leu Ala Arg Arg Ser Leu Ala 
            20                  25                  


<210>  26
<211>  28
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  poly lysine NY-ESO-1 antigen position 91-110

<400>  26

Lys Lys Lys Lys Lys Lys Tyr Leu Ala Met Pro Phe Ala Thr Pro Met 
1               5                   10                  15      


Glu Ala Glu Leu Ala Arg Arg Ser Leu Ala Glu Glu 
            20                  25              


<210>  27
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  poly lysine MAGE-A3 antigen position 161-180

<400>  27

Lys Lys Lys Lys Lys Lys Val Phe Gly Ile Glu Leu Met Glu Val Asp 
1               5                   10                  15      


Pro Ile Gly His Leu Tyr Ile Phe Ala Thr 
            20                  25      


<210>  28
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  poly lysine MAGE-A3 antigen position 161-176

<400>  28

Lys Lys Lys Lys Lys Lys Val Phe Gly Ile Glu Leu Met Glu Val Asp 
1               5                   10                  15      


Pro Ile Gly His Leu Tyr 
            20          


